{ "cik": 1714899, "cik_padded": "0001714899", "entityName": "Denali Therapeutics Inc.", "fiscal_years": [ { "accn": "0001714899-26-000021", "filed": "2026-02-26", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 9502000.0, "cash": 205326000.0, "eps_diluted": -2.97, "free_cash_flow": -422102000.0, "net_income": -512540000.0, "operating_cash_flow": -412600000.0, "operating_income": -555342000.0, "stockholders_equity": 1013761000.0, "total_assets": 1144854000.0, "total_liabilities": 131093000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.1293135166967362, "roa_avg2y": -0.4069337690559159, "roa_period_end": -0.4476902731702034, "roe_avg2y": -0.45692227801439306, "roe_period_end": -0.5055826767847649 } }, { "accn": "0001714899-26-000021", "filed": "2026-02-26", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 15912000.0, "cash": 174960000.0, "eps_diluted": -2.57, "free_cash_flow": -363606000.0, "net_income": -422773000.0, "operating_cash_flow": -347694000.0, "operating_income": -487341000.0, "stockholders_equity": 1229684000.0, "total_assets": 1374180000.0, "total_liabilities": 144496000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.11750661145465013, "roa_avg2y": -0.33445947683178295, "roa_period_end": -0.3076547468308373, "roe_avg2y": -0.3740298092839278, "roe_period_end": -0.34380621362886726 } }, { "accn": "0001714899-26-000021", "filed": "2026-02-26", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 12939000.0, "cash": 127106000.0, "eps_diluted": -1.06, "free_cash_flow": -370930000.0, "net_income": -145224000.0, "operating_cash_flow": -357991000.0, "operating_income": -196699000.0, "stockholders_equity": 1030954000.0, "total_assets": 1153917000.0, "total_liabilities": 122963000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.119271082899916, "roa_avg2y": -0.11110571315669782, "roa_period_end": -0.12585307262134104, "roe_avg2y": -0.14008403653158316, "roe_period_end": -0.14086370487917016 } }, { "accn": "0001714899-26-000021", "filed": "2026-02-26", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 17833000.0, "cash": 218044000.0, "eps_diluted": -2.6, "free_cash_flow": -262549000.0, "net_income": -325991000.0, "operating_cash_flow": -244716000.0, "operating_income": -340744000.0, "stockholders_equity": 1042430000.0, "total_assets": 1460242000.0, "total_liabilities": 417812000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.4008058095027964, "roa_avg2y": -0.22761523863253927, "roa_period_end": -0.22324450330835574, "roe_avg2y": -0.3252233103758578, "roe_period_end": -0.312722197173911 } }, { "accn": "0001714899-25-000066", "filed": "2025-02-27", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 8500000.0, "cash": 293477000.0, "eps_diluted": -2.39, "free_cash_flow": -219889000.0, "net_income": -290581000.0, "operating_cash_flow": -211389000.0, "operating_income": -295751000.0, "stockholders_equity": 962291000.0, "total_assets": 1404162000.0, "total_liabilities": 441871000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.45918646230713994, "roa_avg2y": -0.19317706640181198, "roa_period_end": -0.20694264621888359, "roe_avg2y": -0.27506434522169876, "roe_period_end": -0.30196790783661076 } }, { "accn": "0001714899-24-000086", "filed": "2024-02-28", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3095000.0, "cash": 507144000.0, "eps_diluted": 0.63, "free_cash_flow": 413057000.0, "net_income": 71136000.0, "operating_cash_flow": 416152000.0, "operating_income": 62718000.0, "stockholders_equity": 1150531000.0, "total_assets": 1604280000.0, "total_liabilities": 453749000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3943822461107089, "roa_avg2y": 0.06594265336306512, "roa_period_end": 0.04434138679033585, "roe_avg2y": 0.09206035119232882, "roe_period_end": 0.061828842508372214 } }, { "accn": "0001714899-23-000049", "filed": "2023-02-27", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 17919000.0, "cash": 79449000.0, "eps_diluted": -2.07, "free_cash_flow": -169495000.0, "net_income": -197614000.0, "operating_cash_flow": -151576000.0, "operating_income": -213184000.0, "stockholders_equity": 394890000.0, "total_assets": 553231000.0, "total_liabilities": 158341000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.40097495505077363, "roa_avg2y": -0.3252329834638315, "roa_period_end": -0.35719979538384516, "roe_avg2y": -0.4196806957371235, "roe_period_end": -0.5004279672820279 } }, { "accn": "0001714899-22-000058", "filed": "2022-02-28", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3393000.0, "cash": 77123000.0, "eps_diluted": -0.39, "free_cash_flow": 46723000.0, "net_income": -36240000.0, "operating_cash_flow": 50116000.0, "operating_income": -46372000.0, "stockholders_equity": 546845000.0, "total_assets": 661984000.0, "total_liabilities": 115139000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2105514359644872, "roa_avg2y": -0.06309713982266987, "roa_period_end": -0.054744525547445265, "roe_avg2y": -0.07157521767339067, "roe_period_end": -0.06627106401265441 } }, { "accn": "0001714899-21-000033", "filed": "2021-02-26", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2875000.0, "cash": 218375000.0, "free_cash_flow": -79510000.0, "net_income": -88185000.0, "operating_cash_flow": -76635000.0, "operating_income": -90140000.0, "stockholders_equity": 465796000.0, "total_assets": 486721000.0, "total_liabilities": 20925000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.04492309938256232, "roa_period_end": -0.18118182696041468, "roe_avg2y": -0.47456961269178405, "roe_period_end": -0.18932107617927157 } }, { "accn": "0001714899-20-000026", "filed": "2020-02-27", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD" }, "fundamentals": { "capex": 6134000.0, "cash": 39853000.0, "free_cash_flow": -78042000.0, "net_income": -86652000.0, "operating_cash_flow": -71908000.0, "operating_income": -87433000.0, "stockholders_equity": -94154000.0 }, "period_end": "2016-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001714899-26-000021", "filed": "2026-02-26", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2836", "sic_description": "Biological Products, (No Diagnostic Substances)", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001714899.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001714899.json" }, "ticker": "DNLI" }